TYK Medicines, Inc (HKG:2410)
Hong Kong
· Delayed Price · Currency is HKD 11.10
-0.09 (-0.80%)
Mar 10, 2026, 4:08 PM HKT
TYK Medicines Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -280.08 | -386.96 | -382.43 | -310.99 |
| Depreciation & Amortization | 27.28 | 29.32 | 27.64 | 16.33 |
| Other Amortization | 14.6 | 27.23 | 8 | - |
| Loss (Gain) From Sale of Assets | -0.04 | -0.04 | 0.01 | 0.04 |
| Loss (Gain) From Sale of Investments | 0.26 | 0 | 0.73 | -0.34 |
| Stock-Based Compensation | 5.43 | 12.47 | 3.89 | - |
| Other Operating Activities | 12.43 | 63.32 | 90.17 | 76.57 |
| Change in Accounts Receivable | -33.89 | -46.49 | -11.27 | -19.6 |
| Change in Accounts Payable | -12.12 | -7.11 | 62.32 | -4.89 |
| Change in Other Net Operating Assets | - | - | - | 22.83 |
| Operating Cash Flow | -266.13 | -308.25 | -200.94 | -220.05 |
| Capital Expenditures | -55.35 | -73.62 | -76.38 | -58.97 |
| Sale of Property, Plant & Equipment | 24.66 | 5.01 | 0.07 | 0 |
| Divestitures | 9.94 | 10 | - | - |
| Sale (Purchase) of Intangibles | - | - | -0.88 | -29.21 |
| Investment in Securities | -124.32 | -52.74 | 149.03 | -64.15 |
| Other Investing Activities | -24.51 | -24.51 | 1.17 | -5.84 |
| Investing Cash Flow | -169.58 | -135.86 | 73.01 | -158.17 |
| Short-Term Debt Issued | - | 154.15 | - | - |
| Total Debt Issued | 137.76 | 154.15 | - | - |
| Short-Term Debt Repaid | - | -10.12 | - | - |
| Long-Term Debt Repaid | - | -10.36 | -16.48 | -1.61 |
| Total Debt Repaid | -85.82 | -20.48 | -16.48 | -1.61 |
| Net Debt Issued (Repaid) | 51.94 | 133.67 | -16.48 | -1.61 |
| Issuance of Common Stock | 530.68 | 580.68 | 185 | 325 |
| Repurchase of Common Stock | -13.75 | -13.75 | - | - |
| Other Financing Activities | -45.74 | -68.52 | 55.47 | 27.75 |
| Financing Cash Flow | 523.13 | 632.08 | 224 | 351.14 |
| Foreign Exchange Rate Adjustments | -1.38 | 0.25 | 0.01 | - |
| Net Cash Flow | 86.04 | 188.22 | 96.07 | -27.08 |
| Free Cash Flow | -321.48 | -381.87 | -277.32 | -279.02 |
| Free Cash Flow Margin | -300449.53% | -356891.59% | - | -630.67% |
| Free Cash Flow Per Share | -0.89 | -1.13 | -0.96 | -1.00 |
| Cash Interest Paid | 4.8 | 3.31 | - | - |
| Levered Free Cash Flow | -1,454 | -1,455 | 94.34 | - |
| Unlevered Free Cash Flow | -1,445 | -1,447 | 99.8 | - |
| Change in Working Capital | -46.01 | -53.6 | 51.05 | -1.66 |
Source: S&P Capital IQ. Standard template. Financial Sources.